| Product NDC: | 31722-536 |
| Proprietary Name: | Levetiracetam |
| Non Proprietary Name: | Levetiracetam |
| Active Ingredient(s): | 250 mg/1 & nbsp; Levetiracetam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 31722-536 |
| Labeler Name: | Camber Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090515 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120109 |
| Package NDC: | 31722-536-05 |
| Package Description: | 12 BOTTLE in 1 CASE (31722-536-05) > 500 TABLET, FILM COATED in 1 BOTTLE |
| NDC Code | 31722-536-05 |
| Proprietary Name | Levetiracetam |
| Package Description | 12 BOTTLE in 1 CASE (31722-536-05) > 500 TABLET, FILM COATED in 1 BOTTLE |
| Product NDC | 31722-536 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levetiracetam |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120109 |
| Marketing Category Name | ANDA |
| Labeler Name | Camber Pharmaceuticals |
| Substance Name | LEVETIRACETAM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |